Pediatrix Medical Group 8-K Filing: Key Updates for Investors - January 12, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted and summarized:
- Entity Information:
- Company Name: Pediatrix Medical Group, Inc.
- CIK (Central Index Key): 0000893949
- State of Incorporation: Florida (FL)
- SEC File Number: 001-12111
- Employer Identification Number (EIN): 26-3667538
- Address: 1301 Concord Terrace, Sunrise, FL 33323
- Contact Number: 954-384-0175
- Filing Type:
- Form Type: 8-K (This form is used to report major events that shareholders should know about.)
- Date of Filing:
- Filing Date: January 12, 2025
- Stock Information:
- Common Stock: Par value of $0.01 per share
- Exchange Listing: NYSE (New York Stock Exchange)
- Filing Context:
- This filing reflects a specific duration context where the start and end date is January 12, 2025, indicating it might pertain to an event or condition occurring on the same day.
Insights:
- The 8-K filing indicates that an important event or information regarding Pediatrix Medical Group occurred on January 12, 2025, which warrants disclosure to shareholders.
- The details regarding the common stock suggest that the company is publicly traded and may be subject to regulatory scrutiny concerning its reporting and corporate governance.
- The lack of additional context or event descriptions means that further details would be needed to assess the nature of the event reported in the 8-K filing.
This information is crucial for investors and analysts monitoring Pediatrix Medical Group as it provides insights into significant corporate actions and compliance with SEC regulations.